Evaluating clinical trial design: systematic review of randomized vehicle-controlled trials for determining efficacy of benzoyl peroxide topical therapy for acne

Sonia A. Lamel, Raja K Sivamani, Maral Rahvar, Howard I. Maibach

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Determined efficacies of benzoyl peroxide may be affected by study design, implementation, and vehicle effects. We sought to elucidate areas that may allow improvement in determining accurate treatment efficacies by determining rates of active treatment and vehicle responders in randomized controlled trials assessing the efficacy of topical benzoyl peroxide to treat acne. We conducted a systematic review of randomized vehicle-controlled trials evaluating the efficacy of topical benzoyl peroxide for the treatment of acne. We compared response rates of vehicle treatment arms versus those in benzoyl peroxide arms. Twelve trials met inclusion criteria with 2818 patients receiving benzoyl peroxide monotherapy treatment and 2004 receiving vehicle treatment. The average percent reduction in total number of acne lesions was 44.3 (SD = 9.2) and 27.8 (SD = 21.0) for the active and vehicle treatment groups, respectively. The average reduction in non-inflammatory lesions was 41.5 % (SD = 9.4) in the active treatment group and 27.0 % (SD = 20.9) in the vehicle group. The average percent decrease in inflammatory lesions was 52.1 (SD = 10.4) in the benzoyl peroxide group and 34.7 (SD = 22.7) in the vehicle group. The average percentage of participants achieving success per designated study outcomes was 28.6 (SD = 17.3) and 15.2 (SD = 9.5) in the active treatment and vehicle groups, respectively. Patient responses in randomized controlled trials evaluating topical acne therapies may be affected by clinical trial design, implementation, the biologic effects of vehicles, and natural disease progression. “No treatment” groups may facilitate determination of accurate treatment efficacies.

Original languageEnglish (US)
Pages (from-to)757-766
Number of pages10
JournalArchives of Dermatological Research
Volume307
Issue number9
DOIs
StatePublished - Nov 1 2015

Fingerprint

Benzoyl Peroxide
Acne Vulgaris
Randomized Controlled Trials
Clinical Trials
Therapeutics
Disease Progression
Outcome Assessment (Health Care)

Keywords

  • Acne
  • Benzoyl peroxide
  • Placebo effect
  • Placebo response
  • Randomized controlled trial
  • Study design
  • Topical administration
  • Vehicle delivery

ASJC Scopus subject areas

  • Dermatology

Cite this

Evaluating clinical trial design : systematic review of randomized vehicle-controlled trials for determining efficacy of benzoyl peroxide topical therapy for acne. / Lamel, Sonia A.; Sivamani, Raja K; Rahvar, Maral; Maibach, Howard I.

In: Archives of Dermatological Research, Vol. 307, No. 9, 01.11.2015, p. 757-766.

Research output: Contribution to journalArticle

@article{421b1e7f2a2541b0a59110bf7bc6d76d,
title = "Evaluating clinical trial design: systematic review of randomized vehicle-controlled trials for determining efficacy of benzoyl peroxide topical therapy for acne",
abstract = "Determined efficacies of benzoyl peroxide may be affected by study design, implementation, and vehicle effects. We sought to elucidate areas that may allow improvement in determining accurate treatment efficacies by determining rates of active treatment and vehicle responders in randomized controlled trials assessing the efficacy of topical benzoyl peroxide to treat acne. We conducted a systematic review of randomized vehicle-controlled trials evaluating the efficacy of topical benzoyl peroxide for the treatment of acne. We compared response rates of vehicle treatment arms versus those in benzoyl peroxide arms. Twelve trials met inclusion criteria with 2818 patients receiving benzoyl peroxide monotherapy treatment and 2004 receiving vehicle treatment. The average percent reduction in total number of acne lesions was 44.3 (SD = 9.2) and 27.8 (SD = 21.0) for the active and vehicle treatment groups, respectively. The average reduction in non-inflammatory lesions was 41.5 {\%} (SD = 9.4) in the active treatment group and 27.0 {\%} (SD = 20.9) in the vehicle group. The average percent decrease in inflammatory lesions was 52.1 (SD = 10.4) in the benzoyl peroxide group and 34.7 (SD = 22.7) in the vehicle group. The average percentage of participants achieving success per designated study outcomes was 28.6 (SD = 17.3) and 15.2 (SD = 9.5) in the active treatment and vehicle groups, respectively. Patient responses in randomized controlled trials evaluating topical acne therapies may be affected by clinical trial design, implementation, the biologic effects of vehicles, and natural disease progression. “No treatment” groups may facilitate determination of accurate treatment efficacies.",
keywords = "Acne, Benzoyl peroxide, Placebo effect, Placebo response, Randomized controlled trial, Study design, Topical administration, Vehicle delivery",
author = "Lamel, {Sonia A.} and Sivamani, {Raja K} and Maral Rahvar and Maibach, {Howard I.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1007/s00403-015-1568-9",
language = "English (US)",
volume = "307",
pages = "757--766",
journal = "Archives of Dermatological Research",
issn = "0340-3696",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Evaluating clinical trial design

T2 - systematic review of randomized vehicle-controlled trials for determining efficacy of benzoyl peroxide topical therapy for acne

AU - Lamel, Sonia A.

AU - Sivamani, Raja K

AU - Rahvar, Maral

AU - Maibach, Howard I.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Determined efficacies of benzoyl peroxide may be affected by study design, implementation, and vehicle effects. We sought to elucidate areas that may allow improvement in determining accurate treatment efficacies by determining rates of active treatment and vehicle responders in randomized controlled trials assessing the efficacy of topical benzoyl peroxide to treat acne. We conducted a systematic review of randomized vehicle-controlled trials evaluating the efficacy of topical benzoyl peroxide for the treatment of acne. We compared response rates of vehicle treatment arms versus those in benzoyl peroxide arms. Twelve trials met inclusion criteria with 2818 patients receiving benzoyl peroxide monotherapy treatment and 2004 receiving vehicle treatment. The average percent reduction in total number of acne lesions was 44.3 (SD = 9.2) and 27.8 (SD = 21.0) for the active and vehicle treatment groups, respectively. The average reduction in non-inflammatory lesions was 41.5 % (SD = 9.4) in the active treatment group and 27.0 % (SD = 20.9) in the vehicle group. The average percent decrease in inflammatory lesions was 52.1 (SD = 10.4) in the benzoyl peroxide group and 34.7 (SD = 22.7) in the vehicle group. The average percentage of participants achieving success per designated study outcomes was 28.6 (SD = 17.3) and 15.2 (SD = 9.5) in the active treatment and vehicle groups, respectively. Patient responses in randomized controlled trials evaluating topical acne therapies may be affected by clinical trial design, implementation, the biologic effects of vehicles, and natural disease progression. “No treatment” groups may facilitate determination of accurate treatment efficacies.

AB - Determined efficacies of benzoyl peroxide may be affected by study design, implementation, and vehicle effects. We sought to elucidate areas that may allow improvement in determining accurate treatment efficacies by determining rates of active treatment and vehicle responders in randomized controlled trials assessing the efficacy of topical benzoyl peroxide to treat acne. We conducted a systematic review of randomized vehicle-controlled trials evaluating the efficacy of topical benzoyl peroxide for the treatment of acne. We compared response rates of vehicle treatment arms versus those in benzoyl peroxide arms. Twelve trials met inclusion criteria with 2818 patients receiving benzoyl peroxide monotherapy treatment and 2004 receiving vehicle treatment. The average percent reduction in total number of acne lesions was 44.3 (SD = 9.2) and 27.8 (SD = 21.0) for the active and vehicle treatment groups, respectively. The average reduction in non-inflammatory lesions was 41.5 % (SD = 9.4) in the active treatment group and 27.0 % (SD = 20.9) in the vehicle group. The average percent decrease in inflammatory lesions was 52.1 (SD = 10.4) in the benzoyl peroxide group and 34.7 (SD = 22.7) in the vehicle group. The average percentage of participants achieving success per designated study outcomes was 28.6 (SD = 17.3) and 15.2 (SD = 9.5) in the active treatment and vehicle groups, respectively. Patient responses in randomized controlled trials evaluating topical acne therapies may be affected by clinical trial design, implementation, the biologic effects of vehicles, and natural disease progression. “No treatment” groups may facilitate determination of accurate treatment efficacies.

KW - Acne

KW - Benzoyl peroxide

KW - Placebo effect

KW - Placebo response

KW - Randomized controlled trial

KW - Study design

KW - Topical administration

KW - Vehicle delivery

UR - http://www.scopus.com/inward/record.url?scp=84945484583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945484583&partnerID=8YFLogxK

U2 - 10.1007/s00403-015-1568-9

DO - 10.1007/s00403-015-1568-9

M3 - Article

C2 - 26048131

AN - SCOPUS:84945484583

VL - 307

SP - 757

EP - 766

JO - Archives of Dermatological Research

JF - Archives of Dermatological Research

SN - 0340-3696

IS - 9

ER -